Remove 2017 Remove Clinical Pharmacology Remove Drug Development
article thumbnail

Developing new treatment regimens for HIV

European Pharmaceutical Review

As a physician scientist with knowledge and experience in translational medicine and late-stage drug development, Sherene has a proven record in drug development including successful regulatory interactions with US and international agencies. Internet] 2017. Lancet HIV. 2023;10(5):e295-e307.

article thumbnail

NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials

Putting Patients First Blog

Further discussion on the unique aspects of rare disease drug development, the associated challenges, and when waivers may be warranted would greatly benefit all stakeholders, including sponsors, patient organizations, clinical researchers, and regulators. Clinical Pharmacology & Therapeutics , 97(3) , 263–273.